PEER REVIEWED
Biobran MGN-3: Effect of reducing side effects of chemotherapy in breast cancer patients
Masood AI, Sheikh R, Anwer RA | (edited by Chris Gutch PhD.) | 2013
Objective:
The aim of study was to assess the effect of Biobran in reducing of chemotherapy induced side effects in terms of tiredness, anorexia, vomiting and hair loss and quality of life in terms of weight loss.
Setting:
Radiotherapy Department, Nishtar Hospital Multan.
Material and Methods:
Fifty patients of breast cancer were enrolled randomly in two groups. Group—A patients were given 3 gram dose of Biobran MGN-3 (also known as Lentin Plus 1000) per day one week before and one week after chemotherapy. Group-B patient were given chemotherapy alone. Total six cycles of chemotherapy were given. No multivitamin orfood supplements were given during this study. Chemotherapy induced side effects (tiredness, anorexia, and vomiting, hair loss) were assessed by questionnaire to the patients before start of each cycle. Weight was checked before each cycle to assess weight gain or loss. White blood cells were checked by complete blood count just before and one week after chemotherapy.
Results:
Between six months, 50 patients were enrolled in Radiotherapy Department, Nishtar Hospital Multan. There was asignificant reduction in tiredness and anorexia in group—A patients. 20 (80%) patients of group-A felt increase intheirdiet and notiredness without any appetizeror multivitamin. But group—B patients demanded for appetizer due to severe anorexia after chemotherapy except 3 (12%) patients who didn‘t use any appetizer or food supplement. In group-A, 15 (60%) patients didnt need any anti-emetic as compared to group-B all patient (100%) experienced severe nausea during and after chemotherapy. Group—A patients experienced less hairfall 7 (28%) patients as compared to other group which is 25 (100%) patients.
Conclusions:
The study showed that, by helping to optimize the immune system, Biobran MGN-3 can not only help maximize treatment success, but also minimize treatment side effects and improve quality of life during treatment and in recovery.
Proven Results, Backed by Clinical Research
View all-
Basophilic Response in Patients with Persistent Symptoms Attributed to Lyme Borreliosis Treated with Hydrolysed Arabinoxylan Rice Bran
Background and Objectives: MGN-3/Biobran (BRM4, Lentin Plus 1000 or Ribraxx) is a natural, rice bran-derived arabinoxylan immunoceutical that modulates the adaptive immune response to viral infections. In response to bacterial...
PEER REVIEWEDBasophilic Response in Patients with Persistent Symptoms Attributed to Lyme Borreliosis Treated with Hydrolysed Arabinoxylan Rice Bran
2025Background and Objectives: MGN-3/Biobran (BRM4, Lentin Plus 1000 or Ribraxx) is a natural, rice bran-derived arabinoxylan immunoceutical that modulates the adaptive immune response to viral infections. In response to bacterial...
-
Biobran/MGN-3: A Promising Natural Strategy for Mitigating Kidney Damage and Immune Modulation During Etoposide Therapy
Although chemotherapy is one of the pillars in cancer treatment, its side effects have extremely harmful impacts on many of the body's organs. This study investigates the potential protective effect...
Biobran/MGN-3: A Promising Natural Strategy for Mitigating Kidney Damage and Immune Modulation During Etoposide Therapy
2025Although chemotherapy is one of the pillars in cancer treatment, its side effects have extremely harmful impacts on many of the body's organs. This study investigates the potential protective effect...
-
Nanoparticle Enhanced. The Protective Effects of MGN-3 BioBran Against Ehrlich Ascites Carcinoma-Induced Toxicity in the Liver, Kidneys and Spleen of Mice
Background: Nanoparticle-enabled targeted drug delivery has proven effective in cancer treatment due to its ability to cross biological barriers, achieve therapeutic concentrations within tumors, and minimize adverse effects on surrounding...
Nanoparticle Enhanced. The Protective Effects of MGN-3 BioBran Against Ehrlich Ascites Carcinoma-Induced Toxicity in the Liver, Kidneys and Spleen of Mice
2025Background: Nanoparticle-enabled targeted drug delivery has proven effective in cancer treatment due to its ability to cross biological barriers, achieve therapeutic concentrations within tumors, and minimize adverse effects on surrounding...